YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novo Nordisk parent pens $16.5B acquisition

Posted online

Danish drugmaker Novo Nordisk's parent company, Novo Holdings, has signed on for a $16.5 billion acquisition.

The company is buying drug manufacturer Catalent.

CNBC reports the deal could help shore up the supply of weight loss injection Wegovy and diabetes shot Ozempic.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences